← Back to Search

Behavioral Weight Loss + Cardiac Rehab for Atrial Fibrillation and Obesity (BE-WEL in CR Trial)

N/A
Waitlist Available
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18+ years
Obesity (i.e., BMI ≥30 kg/m2)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12-weeks
Awards & highlights

BE-WEL in CR Trial Summary

This trial will test whether adding behavioral weight-loss treatment to traditional cardiac rehabilitation helps people with atrial fibrillation and obesity experience relief from their symptoms.

Who is the study for?
This trial is for English-speaking adults over 18 with obesity (BMI ≥30) and symptomatic, documented atrial fibrillation that's not permanent. It's not for those with uncontrolled coronary artery disease, in another weight loss program, or scheduled for catheter ablation treatment.Check my eligibility
What is being tested?
The study tests a new behavioural weight-loss treatment added to cardiac rehabilitation (CR) for patients with atrial fibrillation and obesity. It includes supervised exercise sessions twice weekly and online group therapy classes focused on psychological strategies for weight loss.See study design
What are the potential side effects?
While the trial itself may not have direct side effects, participants might experience general discomforts from lifestyle changes such as muscle soreness from increased physical activity or stress related to behavior modification techniques.

BE-WEL in CR Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
My BMI is 30 or higher.
Select...
I have had at least 2 episodes of AF in the last 6 months or an AF episode that lasted 7 days or more.

BE-WEL in CR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12-weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12-weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intervention Acceptability
Intervention Feasibility
Secondary outcome measures
AF-related quality of life
Atrial Fibrillation
Psychological Distress
+1 more

BE-WEL in CR Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
The intervention consists of a traditional 12-week outpatient CR program with added weekly behavioural weight loss classes.

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
780 Previous Clinical Trials
841,709 Total Patients Enrolled
11 Trials studying Atrial Fibrillation
2,452 Patients Enrolled for Atrial Fibrillation

Media Library

Behavioural Weight Loss Treatment Clinical Trial Eligibility Overview. Trial Name: NCT05230823 — N/A
Atrial Fibrillation Research Study Groups: Intervention
Atrial Fibrillation Clinical Trial 2023: Behavioural Weight Loss Treatment Highlights & Side Effects. Trial Name: NCT05230823 — N/A
Behavioural Weight Loss Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT05230823 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

For what size of participant pool is this trial recruiting?

"Affirmative, clinicaltrials.gov reports that this trial is currently accepting recruits. This research project was first posted on January 24th 2022 and underwent its last update in October 2021. A total of 40 volunteers will be taken from a single medical site for the study's duration."

Answered by AI

Is the medical research currently seeking participants?

"Affirmative, the information provided on clinicaltrials.gov states that this research trial is actively recruiting participants. The project commenced on January 24th 2022 and was most recently amended in October 31st 2022. 40 people are needed to enroll from one centre."

Answered by AI

What are the research goals of this investigation?

"This medical trial is expected to last 12 weeks, its primary objective being the evaluation of Intervention Feasibility. Secondary goals include evaluating Atrial fibrillation Effect on Quality-of-Life Questionnaire (AFEQT), Beck Depression Inventory - II (BDI - II) and Beck Anxiety Inventory (BAI) scores for symptoms of Psychological Distress along with University Of Toronto AF Symptom Severity Scale (AFSS). The assessments will measure changes in patient's quality of life over time as well as global wellbeing."

Answered by AI
~4 spots leftby Mar 2025